Nepsis Inc’s NewAge, Inc. Common Stock (Delaware) NBEV Stock Holding History

Nepsis Inc’s Portfolio NBEV Stock Details NBEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-27,558	Closed	-$147K	–	38
2018 Q3	$147K	Sell	27,558 -1,711,632	-98%	-$3.88M	0.08%	37
2018 Q2	$3.25M	Buy	+1,739,190	New	+$3.27M	1.62%	27

Other funds holding NBEV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Nepsis Inc's NBEV Position: Q4 2018 in Review

Nepsis Inc sold out of NewAge, Inc. Common Stock (Delaware) (NBEV) in Q4 2018, closing a stake of 27,558 shares — an estimated $147K sold.

Nepsis Inc first reported a position in NBEV in Q2 2018 and held it in 2 quarters. The position peaked at $3.25M in Q2 2018. 86 funds tracked by Wall St. Rank hold NBEV as of Q4 2018.

Nepsis Inc reported no remaining NewAge, Inc. Common Stock (Delaware) position as of Q4 2018 after selling out during the quarter.
Nepsis Inc sold 27,558 NewAge, Inc. Common Stock (Delaware) shares in Q4 2018, an estimated $147K.
Nepsis Inc first reported a position in NewAge, Inc. Common Stock (Delaware) in Q2 2018 and held it in 2 quarters.
Nepsis Inc's NewAge, Inc. Common Stock (Delaware) position peaked at $3.25M in Q2 2018.
86 funds tracked by Wall St. Rank held NewAge, Inc. Common Stock (Delaware) as of Q4 2018.

Based on Nepsis Inc's 13F filing for Q4 2018, filed 13 Feb 2019.